EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieLeitlinieOpen Access · CC BY 4.0

Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association

Maciej Sterliński iD, Karina V Bunting iD, Giuseppe Boriani iD, Serge Boveda iD, Eduard Guasch iD, Lluís Mont iD, Kim Rajappan iD, Philipp Sommer iD, Samir Mehta iD, Yongzhong Sun iD, Chris P Gale iD, Colinda van Deutekom iD und 3 weitere

Europace · 2024

DOI: 10.1093/europace/euae178 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Europace, 2024. Verfasst von Maciej Sterliński und 14 weiteren Autor:innen. Beteiligte Einrichtung: Arrhythmia Center, National Institute of Cardiology, Warsaw, Poland. Hauptthemen laut MEDLINE: Atrial Fibrillation, Guideline Adherence, Practice Guidelines as Topic. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim, Daiichi Sankyo, and Boston Scientific, BMS/Pfizer Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The aim is to describe the rationale, design, delivery, and baseline characteristics of the Stroke prevention and rhythm control Treatment: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomized trial in patients with Atrial Fibrillation (STEEER-AF) trial. Methods and results STEEER-AF is a pragmatic trial designed to objectively and robustly determine whether guidelines are adhered to in routine practice and evaluate a targeted educational programme for healthcare professionals. Seventy centres were randomized in six countries (France, Germany, Italy, Poland, Spain, and UK; 2022–23). The STEEER-AF centres recruited 1732 patients with a diagnosis of atrial fibrillation (AF), with a mean age of 68.9 years (SD 11.7), CHA2DS2-VASc score of 3.2 (SD 1.8), and 647 (37%) women. Eight hundred and forty-three patients (49%) were in AF at enrolment and 760 (44%) in sinus rhythm. Oral anticoagulant therapy was prescribed in 1543 patients (89%), with the majority receiving direct oral anticoagulants (1378; 89%). Previous cardioversion, antiarrhythmic drug therapy, or ablation was recorded in 836 patients (48.3%). Five hundred fifty-one patients (31.8%) were currently receiving an antiarrhythmic drug, and 446 (25.8%) were scheduled to receive a future cardioversion or ablation. The educational programme engaged 195 healthcare professionals across centres randomized to the intervention group, consisting of bespoke interactive online learning and reinforcement activities, supported by national expert trainers.

Conclusion

The STEEER-AF trial was successfully deployed across six European countries to investigate guideline adherence in real-world practice and evaluate if a structured educational programme for healthcare professionals can improve patient-level care. Clinical Trial Registration Clinicaltrials.gov, NCT04396418.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationGuideline AdherencePractice Guidelines as TopicAgedFemaleHumansMaleMiddle AgedAnti-Arrhythmia AgentsAnticoagulantsCardiologyEuropePractice Patterns, Physicians'Research DesignStrokeTreatment OutcomePragmatic Clinical Trials as TopicMulticenter Studies as TopicRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Atrial fibrillationGuideline adherenceRhythm controlStroke preventionTrial

Substanzen

Anti-Arrhythmia AgentsAnticoagulants

Autor:innen und Institutionen

  • Arrhythmia Center, National Institute of Cardiology, Warsaw, Poland.
  • Institute of Cardiovascular Sciences, University of Birmingham, Medical School, Vincent Drive, Birmingham B15 2TT, UK.
  • Cardiology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Division of Cardiology, Department of Biomedical, Metabolic and Neural Sciences, Policlinico di Modena, University of Modena and Reggio Emilia, Modena, Italy.
  • Heart Rhythm Management Department, Cardiology, Clinique Pasteur, Toulouse, France.
  • Cardiology Department, Clinic Barcelona, Barcelona, Spain.

ORCID-Profile: Maciej Sterliński, Karina V Bunting, Giuseppe Boriani, Serge Boveda, Eduard Guasch, Lluís Mont, Kim Rajappan, Philipp Sommer, Samir Mehta, Yongzhong Sun, Chris P Gale, Colinda van Deutekom, Isabelle C Van Gelder, Dipak Kotecha

Förderung

  • Boehringer Ingelheim
  • Daiichi Sankyo, and Boston Scientific
  • BMS/Pfizer Alliance
  • Birmingham British Heart Foundation Accelerator
  • Bayer
  • Oxford National Institute for Health Research Biomedical Research Centre
  • British Heart Foundation

Zitieren

APA

Sterliński, M., Bunting, K. V., Boriani, G., Boveda, S., Guasch, E., Mont, L., Rajappan, K., Sommer, P., Mehta, S., Sun, Y., Gale, C. P., van Deutekom, C., Van Gelder, I. C., Kotecha, D., & STEEER-AF Trial Team (2024). Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association. Europace. https://doi.org/10.1093/europace/euae178

Vancouver

Sterliński M, Bunting KV, Boriani G, Boveda S, Guasch E, Mont L, et al. Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association. Europace. 2024. doi:10.1093/europace/euae178

BibTeX
@article{Sterliski2024,
  author = {Sterliński, Maciej and Bunting, Karina V and Boriani, Giuseppe and Boveda, Serge and Guasch, Eduard and Mont, Lluís and Rajappan, Kim and Sommer, Philipp and Mehta, Samir and Sun, Yongzhong and Gale, Chris P and van Deutekom, Colinda and Van Gelder, Isabelle C and Kotecha, Dipak and STEEER-AF Trial Team, STEEER-AF Trial Team},
  title = {Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association},
  journal = {Europace},
  year = {2024},
  doi = {10.1093/europace/euae178}
}
Kostenlos starten →